1. Home
  2. BDSX vs GECC Comparison

BDSX vs GECC Comparison

Compare BDSX & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$16.43

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

GECC

Great Elm Capital Corp.

HOLD

Current Price

$4.74

Market Cap

69.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
GECC
Founded
2005
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
69.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDSX
GECC
Price
$16.43
$4.74
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$32.50
$10.75
AVG Volume (30 Days)
139.9K
139.1K
Earning Date
05-21-2026
01-01-0001
Dividend Yield
N/A
25.32%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,499,000.00
N/A
Revenue This Year
$23.35
$6.15
Revenue Next Year
$19.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$4.63
52 Week High
$20.21
$11.45

Technical Indicators

Market Signals
Indicator
BDSX
GECC
Relative Strength Index (RSI) 57.36 18.27
Support Level $6.33 N/A
Resistance Level N/A $7.16
Average True Range (ATR) 1.91 0.29
MACD -0.10 -0.10
Stochastic Oscillator 53.31 7.07

Price Performance

Historical Comparison
BDSX
GECC

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generates both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses. The Company operates as a single reportable segment with an investment objective to generate both current income and capital appreciation through debt and equity investments and manages the business on a consolidated basis.

Share on Social Networks: